Related Experiment Video
Updated: Aug 10, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
Prolactin-dependent mitogenesis in Nb 2 node lymphoma cells: effects of immunosuppressive cyclopeptides
Abstract:
Prolactin (PRL)-stimulated ornithine decarboxylase (ODC) activity and subsequent proliferation are inhibited by the cyclopeptides cyclosporine (CsA) and didemnin B (DB) in Nb 2 node lymphoma cells. Similar concentrations of these agents also inhibit 125I-PRL binding, suggesting that their inhibitory effects on these PRL-dependent physiologic responses are mediated at least in part at the level of PRL receptor interactions. The phorbol ester TPA stimulated ODC activity and [3H]thymidine incorporation to 54% and 31% that of a near-optimal mitogenic concentration of PRL (10 ng/ml), suggesting that mitogenesis in these cells is coupled to some degree to the activation of protein kinase C (PKC). The calcium ionophore A23187 increased ODC activity only slightly and actually decreased [3H]thymidine incorporation to a value below the "cells only" controls. The addition of TPA plus A23187 did not further enhance the effects of TPA to elevate ODC activity and [3H]thymidine incorporation. However, A23187 significantly elevated PRL-stimulated ODC activity with a subsequent inhibition of [3H]thymidine incorporation, suggesting a block of entry into S phase. Both cyclopeptides decreased the elevation of ODC activity in G1 phase of cell cycle in response to PRL, suggestive of a site of action for these agents in early G1, a conclusion compatible with their ability to inhibit PRL binding to these cells. Addition of CsA or DB 2 hr after PRL had no effect on PRL-stimulated ODC activity detectable at 6 hr, but addition of either as late as 6 hr still affected the extent of mitogenesis. This is in line with the requirement for PRL to be present in the culture medium for a minimum of 3 to 6 hr to invoke a maximal effect on mitogenesis. Addition of either cyclopeptide after the cells were in S phase had no effect on the extent of [3H]thymidine incorporation. An inhibitor of the cyclooxygenase pathway (indomethacin) enhanced both PRL-stimulated ODC activity and proliferation, whereas inhibition of the lipoxygenase pathway by NDGA attenuated only proliferation, suggesting that in Nb 2 cells, products of the lipoxygenase pathway may contribute to the mechanism of PRL-stimulated mitogenesis. Because Nb 2 lymphoma cells were derived from estrogenized rats, estrogen was tested as a mitogen. By itself it was not mitogenic, but in conjunction with PRL, estradiol-17 beta elevated the ODC response and inhibited proliferation. Inhibitors of PKC known to have minimal effects on RNA synthesis, quercetin and gossypol, totally inhibited both the elevations of ODC activity and [3H]thymidine incorporation in response to PRL in Nb 2 lymphoma cells.(ABSTRACT TRUNCATED AT 400 WORDS)
Insights
Cyclosporine and didemnin B inhibit prolactin-stimulated cell growth by interfering with prolactin receptor interactions. Protein kinase C activation is involved in prolactin-mediated mitogenesis in Nb 2 lymphoma cells.
Area of Science:
- Cell Biology
- Endocrinology
- Pharmacology
Background:
- Prolactin (PRL) stimulates ornithine decarboxylase (ODC) activity and cell proliferation in Nb 2 node lymphoma cells.
- Cyclopeptides cyclosporine (CsA) and didemnin B (DB) are known to modulate cellular processes.
Purpose of the Study:
- To investigate the mechanism by which CsA and DB inhibit PRL-stimulated mitogenesis in Nb 2 cells.
- To explore the role of protein kinase C (PKC) and other signaling pathways in PRL-mediated cell growth.
Main Methods:
- Nb 2 node lymphoma cells were treated with PRL, CsA, DB, phorbol ester TPA, calcium ionophore A23187, indomethacin, NDGA, and estradiol-17 beta.
- PRL binding assays were performed.
- ODC activity and [3H]thymidine incorporation were measured as indicators of cell proliferation.
Main Results:
- CsA and DB inhibited PRL-stimulated ODC activity and proliferation, and also inhibited 125I-PRL binding, suggesting interference with PRL receptor interactions.
- TPA stimulated ODC activity and proliferation, indicating a role for PKC in PRL mitogenesis.
- A23187 modulated ODC activity and proliferation, suggesting effects on cell cycle progression.
- Inhibitors of the cyclooxygenase and lipoxygenase pathways affected PRL-stimulated responses.
- Estrogen alone was not mitogenic but modulated PRL effects.
Conclusions:
- CsA and DB likely inhibit PRL-dependent responses by interacting with the PRL receptor.
- PKC activation is a component of the PRL-stimulated mitogenic pathway in Nb 2 cells.
- Products of the lipoxygenase pathway may contribute to PRL-stimulated mitogenesis.

